ABSTRACT Background: Celiac disease (CD) has emerged as a common, but largely undiagnosed health problem. Numerous studies examined the influence of infant nutrition on the development of diagnosed CD. However, results are still inconsistent. In addition, the effect of infant feeding practices on the development of potential forms of CD might be different.
INTRODUCTION
Celiac disease (CD) 5 has emerged as a common, but largely undiagnosed, health problem (1, 2) . Untreated CD is associated with excess morbidity in children and adults (3) . CD is characterized by an adaptive T cell-mediated response against gluten, classically resulting in chronic inflammation of the small intestinal mucosa and gastrointestinal complaints (4, 5) . However, the clinical presentation of CD has changed over the past few decades to include milder, nonclassic forms (6, 7) . Therefore, diagnosed CD only represents the more visible tip of the iceberg, ie, children having clinical symptoms, whereas asymptomatic or atypical cases are often missed (6) .
Both human leukocyte antigen (HLA) DQ2/DQ8 carrier status and gluten exposure are prerequisites to develop CD. Breastfeeding and the timing of gluten exposure might influence the risk of CD. Underlying mechanisms remain uncertain but might involve a complex interplay between innate and adaptive immune responses, gut colonization, intestinal membrane permeability, genetic predisposition, and environmental factors such as infections and infant feeding habits (8) (9) (10) .
Numerous studies examined the influence of infant nutrition, including breastfeeding and the timing of gluten introduction, on the development of diagnosed CD. On the basis of current literature, the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Committee on Nutrition recommends to avoid both early (,4 mo) and late (.7 mo) introduction of gluten and to introduce gluten gradually while the child is still being breastfed (11) . However, results are still inconsistent in this respect (7, 9, (12) (13) (14) (15) (16) (17) (18) (19) . The lack of consistency between studies may be due to the majority of these studies being retrospective (ie, comparing history of infant feeding practices in CD cases compared with controls) (13, 17, 18, 20) or ecological (ie, linking incidence rates of diagnosed CD to national infant feeding practices) (1) . These latter studies were mainly based on clinical CD. However, because subclinical, silent, or latent forms of CD might exist (4), it could be speculated that these forms have different etiologies, but these are not fully understood. Therefore, the effect of infant feeding practices on the development of subclinical, silent or latent forms of CD might be different (17, 21) . For example, a Swedish study found a decreased prevalence of symptomatic CD after new infant feeding recommendations were introduced but did not find any difference in the prevalence of undiagnosed (screening detected) CD (21) . However, a later replication within the same cohort study did not support these findings (19) . The aim of the current study was to examine whether breastfeeding duration and the timing of gluten introduction were associated with CD autoimmunity (CDA) in a population-based prospective cohort study in 6-y-old children.
SUBJECTS AND METHODS

Participants and study design
This study was embedded in the Generation R Study, a prospective population-based cohort study from fetal life onward, and has been described in detail previously (22) . A total of 8305 mothers with a delivery date from April 2002 through January 2006 provided consent for school age follow-up. Ethical approval for the study was obtained from the Medical Ethical Committee of the Erasmus MC, University Medical Center Rotterdam.
Duration of breastfeeding
Information with regard to breastfeeding was obtained by a combination of delivery reports and postnatal questionnaires at the ages of 2, 6, and 12 mo (22) . Mothers were asked by questionnaire whether they had ever breastfed their child and, if yes, at what age (in mo) they had stopped breastfeeding. Breastfeeding duration was categorized as reported by Størdal et al (14) but later dichotomized as ,6 mo and $6 mo because only 1 infant still received breast milk at the age of 13 mo. Questionnaire response rates were 82%, 73%, and 72% at age 2, 6, and 12 mo, respectively.
Introduction of gluten in the first year of life
At the child's age of 6 and 12 mo, parents were asked by questionnaire the age of first-time introduction of gluten in their infant's diet. In addition, parents were asked to complete a short food-frequency questionnaire consisting of food products frequently consumed according to a Dutch food consumption survey in infants (23) . The timing of gluten introduction was cross-checked with the consumption of bread and biscuits and type of porridge (based on wheat or oats instead of rice) at the age of 6 and 12 mo, as described previously (24) . The timing of the introduction of gluten was categorized as ,6 mo or $6 mo.
Anti-tissue transglutaminase concentrations
Anti-tissue transglutaminase (anti-tTG) concentrations were assessed in venous serum samples by using fluorescence enzyme immunoassay (ELiA Celikey IgA, PhadiaImmunocap 250; Phadia AB) at the Department of Immunology, Erasmus MCUniversity Medical Center Rotterdam, The Netherlands. The intra-and interassay CVs were below 10% and 15%, respectively. Of 8305 children participating at the age of 6 y, serum anti-tTG was available in 53% of children. We excluded 20 children in whom IgA concentrations were low, possibly indicating IgA deficiency. None of the participants were aware of tTG-IgA determination. The median anti-tTG concentration in the study population was 0.25 U/mL, varying from 0.10 to 125 U/mL. Anti-tTG concentrations were categorized into negative and positive by using the cutoff for clinical practice of 7 U/mL ( Figure 1) . Positive anti-tTG concentrations were further categorized into 2 categories based on $10 times the upper limit of normal (ULN) values of the test kit (cutoffs for positive anti-tTG: $7-70 and $70 U/mL) ( Figure 1 ) (25) .
Detection of HLA risk alleles
To capture whether the children carried the HLA-DQ risk type DQ2 or DQ8, a tag nucleotide polymorphism (single nucleotide polymorphism) approach was used as was described in detail previously (26, 27) . Children were genotyped for these single nucleotide polymorphisms for HLA-DQ2 (rs2187668, rs2395182, rs4713586, and rs7775228) and DQ8 (rs7454108) (26) by using genome-wide Illumina 610 Quad Array. Genotype and allele frequencies were in Hardy-Weinberg equilibrium (rs2187668, P = 0.71; rs2395182, P = 0.85; rs4713586, P = 0.57; rs7775228, P = 0.92; and rs7454108, P = 0.76).
Covariates
Data on potential confounders such as fetal sex, gestational age, birth weight, and cesarean section (no differentiation was made between planned and unplanned) were obtained from obstetric records assessed in midwife practices and hospitals (22) . Maternal anti-tTG concentrations were measured during pregnancy. Data on other sociodemographic and lifestyle factors were obtained by a combination of pre-and postnatal questionnaires completed by both parents. This included information on ethnicity (Western or non-Western) (28), parity, maternal smoking 4 Values are means 6 SDs. during pregnancy, maternal educational level (low or high) (29) , and household income per month (#€2200 or .€2200) (30) . Postnatal questionnaires included information on vitamin D supplementation, gastrointestinal and respiratory tract infections, and day care attendance in the first year.
Population for analyses
Of all children with anti-tTG data available (n = 4442), we excluded from the analysis those with diagnosed CD (n = 8) at the age of 6 y and children who were HLA-DQ2/DQ8 negative (n = 2382). To prevent clustering, only one child per family within the Generation R cohort was included by random selection (n = 373). In total, 1679 children were available for statistical analyses (Figure 1 ).
Statistical analysis
First, independent Student's t test and chi-square tests were performed to test for differences in characteristics between groups of anti-tTG concentrations. Second, logistic regression analysis was performed with anti-tTG concentration at the age of 6 y as a dependent variable. Breastfeeding and the timing of gluten introduction were analyzed separately as independent variables and adjusted for major confounders. Because of the small numbers in the positive anti-tTG group, the selection of potential confounders in the multivariate model was restricted to those with an alteration of $10% in ORs (31) . To assess whether the association between breastfeeding or the timing of gluten introduction and anti-tTG concentrations differed by ethnicity and children with and without gastrointestinal infections during infancy, statistical interactions were evaluated by adding the product term of independent variable and subgroup (independent variable 3 subgroup) as covariates to the univariate model. To reduce attrition bias, multiple imputation of the exposures (ie, breastfeeding and timing of gluten introduction) and covariates was performed (n = 5 imputations). The multiple imputation procedure was based on the correlation between each variable with missing values with other subject characteristics (32) . The pooled results of the 5 imputed data sets are reported in this article as ORs and 95% CIs. A P value ,0.05 was considered significant. The statistical analyses were performed in SPSS 20.0 for Windows (SPSS, Inc).
RESULTS
Maternal and child characteristics of the study population are shown in Table 1 . In all 1679 HLA-DQ2/DQ8-positive children, 2.6% had positive anti-tTG concentrations and 97.4% had negative anti-tTG concentrations (Table 1 and Figure 1 ). Of children with positive anti-tTG concentrations (n = 43), 60% (n = 26) had values $10 times the ULN ($70 IU/mL) ( Table 1 and Figure 1) . Breastfeeding for $6 mo was reported in 47% of children with positive and negative anti-tTG concentrations (Figure 2) . The introduction of gluten from the age of 6 mo onward was reported in 56% and 64% of children with positive and negative anti-tTG concentrations, respectively (Figure 2 ).
Breastfeeding and anti-tTG concentrations
Relative to breastfeeding for ,6 mo, breastfeeding for $6 mo was not significantly associated with positive anti-tTG concentrations ( Table 2 ). In addition, breastfeeding for $6 mo was not significantly associated with positive anti-tTG concentrations below or above 10 times the ULN ($70 IU/mL) ( Table 3 ). In comparison with breastfeeding for ,3 mo, breastfeeding between 3 and 6 mo and for $6 mo was not significantly associated with anti-tTG concentrations (data not shown). No significant interaction was found between breastfeeding and ethnicity or gastrointestinal infections during infancy (P-interaction . 0.50).
Timing of gluten introduction and anti-tTG concentrations
In comparison with the introduction of gluten before the age of 6 mo, the introduction of gluten from the age of 6 mo onward was not significantly associated with positive anti-tTG concentrations ( Table 4 ). In addition, the introduction of gluten from the age of 6 mo onward was not significantly associated with positive anti-tTG concentrations below or above 10 times the ULN ($70 IU/mL) ( Table 5) . No significant interaction was found between the timing of gluten introduction and ethnicity or gastrointestinal infections during infancy (P-interaction . 0.69).
DISCUSSION
In this population-based prospective birth cohort, we did not find an association with breastfeeding duration and the timing of gluten introduction and positive anti-tTG concentrations in children with CDA at the age of 6 y.
The ESPGHAN Committee on Nutrition recommends that both early and late introduction of gluten should be avoided. In addition, it is recommended to introduce gluten in small amounts into the diet when the infant is still being breastfed (11). However, evidence for avoiding very early and late introduction of gluten for the prevention of CD is inconsistent. We did not find a relation between the timing of gluten introduction and the risk of CD in childhood, which is in accordance with other studies (13, 15, 17) . In contrast, findings of 2 other prospective studies support a role for the timing of gluten introduction (9, 14) . Norris et al (9) found an increased risk of biopsy-confirmed CD in CDA-positive children for both early (#3 mo) and late ($7 mo) introduction of gluten (9) . Strikingly, before restricting their analyses to biopsy-confirmed CD, Norris et al did not find late introduction to increase the risk of CDA. This suggests that the timing of gluten introduction may be differentially associated with biopsy-confirmed and non-biopsy-confirmed CD. However, diagnosed CD is subject to bias, depending on the awareness of the pediatricians to make the diagnosis. In addition, Norris et al focused on high-risk children defined as having a firstdegree relative with type 1 diabetes or having HLA genotypes associated with CD and type 1 diabetes. Therefore, the results cannot be directly extrapolated to our study. Very recently, the Norwegian Mother and Child Cohort Study (14) found late ($7 mo) but not early (#4 mo) introduction to be borderline associated with an increased risk of CD (adjusted OR: 1.27; 95% CI: 1.01, 1.65). We could not confirm these results in our study, nor did we find the effect estimates in the same direction (adjusted OR: 0.64; 95% CI: 0.31, 1.3). However, the Norwegian Mother and Child Cohort Study included children with clinical CD instead of CDA, which may explain the different results.
The results of our study on breastfeeding and the development of CDA are in line with the findings of other prospective studies (9, 15, 33) . Størdal et al (14) also did not find breastfeeding for $6 mo (6-12 mo) to be associated with CD but found breastfeeding beyond 12 mo to be associated with an increased risk of CD. The majority of children in our cohort did not breastfeed after the age of 12 mo; therefore, we were unable to replicate this analysis (14) . Several studies did find breastfeeding to reduce the risk of CD (12, 17) , especially breastfeeding at the time of (13, 34, 35) and beyond (12, 13, 19, 35 ) the introduction of gluten, as well as with gradual introduction of gluten while breastfeeding (12, 13, 19) . However, most of these studies were based on retrospectively collected data, which may lead to recall bias (ie, differential reporting on infant feeding practices in those with and without CD diagnosis) (13, 17, 18, 20, 35) . In addition, it remains unclear whether the protective effect of breastfeeding is persistent or only delays the onset of symptoms and therefore CD diagnosis (12, 20, 34, 35) . For example, previous studies found longer breastfeeding (35) and breastfeeding exclusivity (18) only to delay the onset of CD in infancy. This may explain why we did not find any association between breastfeeding duration and CDA. Although we did not find breastfeeding duration and the timing of gluten introduction to be associated with CDA, we do not exclude the role of infant feeding in the development of CD. Breastfeeding and the timing of gluten introduction might not be protective for the development of subclinical, silent, or latent forms of CD but could protect against developing symptomatic CD. Also, gluten introduction while breastfeeding and the amount of gluten could be more important than the duration of breastfeeding and the timing of gluten introduction, as suggested by Ivarsson et al (13) .
An important strength of this study is, first, the assessment of serum anti-tTG concentrations and HLA testing in the general CIs) . anti-tTG, anti-tissue transglutaminase; aOR, adjusted OR; ULN, upper limit of normal.
2 Adjusted for smoking during pregnancy, cesarean section, parity, day care attendance in first year, respiratory tract infections in first year, vitamin D supplementation at age 6-12 mo, household income per month, and maternal educational level. Additional adjustment for sex, ethnicity, birth weight z score, timing of gluten introduction, gastrointestinal tract infections in the first year, and maternal anti-tTG concentration did not provide an alteration of $10% in ORs.
pediatric population, which are good methods to detect clinically silent CD (6) . Previous studies selected children with diagnosed CD (17) , or with symptomatic CD leading to CD diagnosis (13, 15) , or focused on high-risk children (9) . Second, we subdivided positive anti-tTG concentrations ($7 U/mL) into 2 groups based on 10 times the ULN value ($70 IU/mL), because positive antitTG concentrations $10 times the ULN show high diagnostic accuracy (25) . Of all anti-tTG-positive children in our study population, .60% had anti-tTG concentrations $10 times the ULN, suggesting that these children likely have CD. Third, our study design provided information on a broad range of potential confounders, including ethnicity, socioeconomic status, smoking during pregnancy, and infections.
Some limitations should be taken into account in the interpretation of the results. Information on breastfeeding duration and the timing of gluten introduction was obtained by parental self-report. Nevertheless, only if misclassification of infant feeding practices were related to CD diagnosis would it have influenced our results, which is unlikely because questionnaires on feeding practices were completed before anti-tTG measurement at 6 y of age. In addition, participants in our study were unaware of tTG-IgA determination, so a response bias is therefore highly unlikely. Also, it may be questioned whether our study had sufficient power to detect small differences in gluten introduction practices between children with and without CDA development. Our study had a power of 80% (at an a of 0.05) to detect at least a 22% difference in gluten at $6 mo to be significant between children with and without CDA. A recent study (19) (n = 13,279) found a difference of 2.5% in gluten at .6 mo to be significant, whereas Norris et al (9) found a difference of 12% to be significant (n = 1560). Although the sensitivity and specificity of anti-tTG are high (25, 36) , only when anti-tTG concenetrations are $10 times the ULN in combination with symptoms and positive anti-endomysial antibody can (clinical) CD be diagnosed without duodenal biopsy (25) . According to the ESPGHAN, clinically diagnosed CD concerns children who visit the pediatrician because of symptoms, whereas subclinical CD is found by screening and must be verified by biopsy specimens. However, because our study did not have biopsy specimens, we examined the development of CDA. Therefore, final conclusions concerning (subclinical) CD diagnosis should be made with caution. Furthermore, we adjusted for potential confounders in our analysis, but residual confounding cannot be fully excluded. Another limitation of this study is that our study cannot examine the effect of gluten introduction before the age of 4 mo, as well as the amount of gluten introduced in relation to anti-tTG concentrations. Although a previous study in Dutch infants showed that the majority of children receive gluten between 3 and 6 mo of age and not before that time (37) , a window of opportunity in which gluten introduction might prevent CDA cannot be fully ruled out. In relation to breastfeeding, this study cannot examine the effect of breastfeeding at the time of and beyond gluten introduction. Hence, our study precludes conclusions on the effect of very early introduction of gluten, gradual introduction of gluten, and the introduction while breastfeeding.
In conclusion, the results suggest that a delayed introduction of gluten beyond the age of 6 mo does not increase the risk of CDA. In addition, breastfeeding for $6 mo does not decrease the risk of CDA in children at 6 y of age. Our study precludes conclusions on the timing of gluten introduction while breastfeeding.
The Generation R Study is conducted by the Erasmus MC, Erasmus University Rotterdam, in close collaboration with the School of Law and Faculty of Social Sciences of the Erasmus University Rotterdam, the Municipal Health Service Rotterdam Metropolitan Area, the Rotterdam Homecare Foundation, and the Stichting Trombosedienst & Artsenlaboratorium Rijnmond. We gratefully acknowledge the contributions of children and parents, general practitioners, hospitals and midwives, and pharmacies in Rotterdam.
The authors' responsibilities were as follows-VWVJ, AH, and HAM: designed the research; MAEJ, IIMT, and JCK-dJ: conducted the research and analyzed the data or performed statistical analysis; MAEJ and IIMT: wrote the manuscript; HAM: had primary responsibility for final content; and HH and JCE: contributed to the interpretation of the data and revised the 2 Adjusted for ethnicity and household income per month. Adjustment for sex, birth weight z score, smoking during pregnancy, breastfeeding, parity, cesarean section, day care attendance, vitamin D supplementation, gastrointestinal and respiratory tract infections in the first year, maternal educational level, and maternal anti-tTG concentration did not provide an alteration of $10% in ORs. 
